Biocept Awarded Accreditation by the College of American Pathologists

Thursday, December 4, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

SAN DIEGO, Dec. 3 Biocept, Inc. ("Biocept"), an emergingleader in biotechnology, announced today their CLIA laboratory has beenawarded accreditation by the Commission on Laboratory Accreditation of theCollege of American Pathologists (CAP), based on the results of a recenton-site inspection. The laboratory's director, Philip D. Cotter, Ph.D., FACMG,was advised of this national recognition and congratulated for the "excellenceof services being provided."

About Biocept

Biocept, an emerging biotechnology leader in cell separation technology,is developing a new, powerful class of diagnostic assays for personalizedmedicine in early detection, diagnosis and monitoring of cancer. The CEE(TM)Cell Enrichment and Extraction platform combines sophisticated attachmentchemistry with mathematically modeled fluid dynamics and nanotechnology toenable earlier, accurate, less invasive diagnoses. Isolation, purification andanalysis of rare cells, such as circulating tumor cells, are managed withinour state-of-the-art CLIA-accredited laboratory. The clinical laboratory isaccredited by the College of American Pathologists (CAP) and holds licenses inCalifornia and several other states.

SOURCE Biocept, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store